1.60Open1.65Pre Close1 Volume1 Open Interest3.00Strike Price160.00Turnover0.00%IV2.78%PremiumDec 20, 2024Expiry Date1.56Intrinsic Value100Multiplier24DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.93Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Vivani Medical Stock Discussion
Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia
NPM-115 clinical program utilizes a miniature, GLP-1 (exenatide) implant designed to provide comparable efficacy to semaglutide, the active ingredient in Ozempic®/Wegovy®, with twice-yearly administration
Study will represent the first clinical application of NanoPortal™, the Company's proprietary drug implant pla...
EXCLUSIVE: Vivani Medical Tells Benzinga 'Felines Share Many Pathophysiologic Obesity Phenotypes With Humans, Further Supporting Clinical Evaluations of Miniature, Subdermal GLP-1 Implants for Obesity Reduction'
$Vivani Medical (VANI.US)$
📊⚡️📊
No comment yet